Press release
Nanoparticle Analysis Market to Reach USD 5.6 Billion by 2035 as AI-Based Drug Formulation, mRNA Delivery, and Multi-Modal Analytics Reshape Biopharma Research
Nanoparticle Analysis Market by Technology, Product Type, Particle Type Analyzed, Parameter Measured, Sample Type, End-use
According to MarketGenics Global Research, the global nanoparticle analysis market is valued at USD 3.5 billion in 2025 and is projected to reach USD 5.6 billion by 2035, expanding at a CAGR of 4.9% during the forecast period. The market is projected to create an incremental opportunity of nearly USD 2 billion through 2035.
Unlike conventional analytical instrumentation markets, nanoparticle analysis is now becoming deeply embedded within next-generation pharmaceutical R&D, nanomedicine commercialization, biologics manufacturing, exosome therapeutics, and AI-integrated laboratory ecosystems.
The growing complexity of nanoscale formulations, increasing regulatory scrutiny surrounding drug stability and reproducibility, and rapid commercialization of mRNA therapeutics are fundamentally increasing demand for high-resolution particle characterization technologies capable of delivering real-time analytical precision across biopharmaceutical workflows.
Get Sample Copy of the Report: https://marketgenics.co/download-report-sample/nanoparticle-analysis-market-04132
==============================
LNP CHARACTERIZATION, mRNA PIPELINES & NANOMEDICINE EXPANSION DRIVING MARKET MOMENTUM
==============================
One of the strongest structural demand catalysts reshaping the nanoparticle analysis market is the rapid expansion of lipid nanoparticle (LNP)-based therapeutics and precision drug delivery platforms.
Biopharmaceutical companies are increasingly prioritizing advanced nanoparticle characterization systems to improve:
• particle size distribution analysis
• colloidal stability validation
• surface charge measurement
• formulation reproducibility
• nanoscale morphology analysis
• drug encapsulation efficiency
• targeted delivery optimization
• biologics formulation performance
As mRNA therapeutics, gene therapy platforms, and nanomedicine applications continue scaling globally, pharmaceutical developers are deploying increasingly sophisticated analytical workflows capable of supporting regulatory-grade nanoparticle characterization across research, formulation, and manufacturing environments.
The market is also witnessing rising adoption of:
• AI-assisted particle interpretation
• predictive formulation analytics
• automated nanoparticle sizing
• cloud-based laboratory ecosystems
• integrated analytical software
• multi-modal characterization platforms
• real-time nanoscale monitoring
This transition is transforming nanoparticle analysis from a laboratory support function into a strategic analytical intelligence layer within precision therapeutics and next-generation drug development ecosystems.
==============================
AI-ENABLED ANALYTICAL WORKFLOWS ARE TRANSFORMING PHARMACEUTICAL LABORATORIES
==============================
Artificial intelligence and automated laboratory systems are rapidly reshaping the analytical architecture of nanoparticle characterization workflows.
Pharmaceutical and biotechnology companies are increasingly integrating AI-enabled analytical platforms capable of:
• automated data interpretation
• predictive nanoparticle modeling
• intelligent formulation screening
• cloud-connected analytics
• real-time characterization optimization
• high-throughput nanoparticle screening
• automated quality validation
The integration of machine learning algorithms and digital laboratory ecosystems is significantly improving analytical reproducibility, operational efficiency, and formulation development speed across nanomedicine and biopharmaceutical R&D environments.
In 2024, Thermo Fisher Scientific launched an automated nanoparticle analysis workflow platform integrating electron microscopy, advanced software, and data-driven automation to improve nanoparticle processing consistency and analytical efficiency across pharmaceutical research applications.
Cloud-based analytical infrastructures are also enabling faster collaboration between pharmaceutical companies, CROs, biotechnology laboratories, and academic research institutions by supporting scalable, real-time analytical workflows across distributed research environments.
==============================
DYNAMIC LIGHT SCATTERING (DLS) MAINTAINS TECHNOLOGY LEADERSHIP ACROSS BIOPHARMA APPLICATIONS
==============================
Dynamic Light Scattering (DLS) continues dominating the global nanoparticle analysis market, accounting for approximately 33% market share in 2025 due to its speed, non-destructive analytical capability, cost efficiency, and broad adoption across pharmaceutical and biotechnology applications.
DLS technologies are extensively deployed across:
• lipid nanoparticle characterization
• mRNA formulation development
• nanomedicine research
• biologics manufacturing
• colloidal stability testing
• drug delivery optimization
• exosome characterization
• nano-enabled diagnostics
Nanoparticle Tracking Analysis (NTA) is also gaining strong commercial traction due to its capability to provide high-resolution single-particle concentration analysis, particularly across exosome therapeutics, extracellular vesicle analysis, and precision diagnostics research.
Integrated analytical workflows combining:
• Dynamic Light Scattering (DLS)
• Nanoparticle Tracking Analysis (NTA)
• Cryo-TEM imaging
• Atomic Force Microscopy (AFM)
• Raman spectroscopy
• AI-assisted analytical software
are increasingly becoming standard across advanced biopharmaceutical laboratories seeking higher nanoscale characterization accuracy and improved analytical reproducibility.
==============================
MULTI-MODAL NANOPARTICLE ANALYTICS EMERGE AS THE NEXT EVOLUTION OF PRECISION BIOPHARMA RESEARCH
==============================
The nanoparticle analysis industry is rapidly shifting toward hybrid analytical ecosystems capable of combining multiple characterization techniques within integrated digital laboratory workflows.
These next-generation systems are designed to improve:
• nanoscale imaging precision
• morphology characterization
• formulation validation
• analytical reproducibility
• molecular-level interpretation
• particle aggregation analysis
• real-time formulation optimization
In June 2025, Malvern Panalytical announced a multi-modal LNP characterization workflow integrating DLS, NTA, AF4, and Cryo-TEM technologies to improve particle analysis for mRNA drug delivery applications.
The integration of AI-assisted analytics within these hybrid systems is further enhancing:
analytical speed,
data reliability,
automated interpretation,
and pharmaceutical decision-making accuracy.
As precision medicine and nanotherapeutic pipelines become more complex, multi-modal nanoparticle characterization platforms are expected to become foundational analytical infrastructure across global biopharma ecosystems.
==============================
NORTH AMERICA LEADS GLOBAL NANOPARTICLE ANALYSIS MARKET EXPANSION
==============================
North America currently dominates the global nanoparticle analysis market, accounting for approximately 35-40% of total market share in 2025.
Regional growth is being supported by:
• advanced pharmaceutical R&D infrastructure
• biotechnology innovation ecosystems
• nanomedicine commercialization
• strong research funding environments
• rapid AI laboratory adoption
• precision medicine investment
• advanced analytical instrumentation deployment
The United States continues maintaining dominant market positioning due to strong FDA-regulated pharmaceutical ecosystems, growing mRNA therapeutic pipelines, expanding biopharmaceutical manufacturing capacity, and increasing deployment of AI-enabled analytical platforms across research laboratories.
The region is also benefiting from rapid integration of:
cloud-connected laboratory systems,
intelligent analytical software,
automated formulation validation,
and high-throughput nanoparticle screening workflows.
Asia Pacific is emerging as a major strategic growth center driven by expanding pharmaceutical manufacturing, biotechnology investments, semiconductor nanomaterials research, and increasing precision medicine adoption across China, Japan, South Korea, and India.
==============================
COMPETITIVE LANDSCAPE & INDUSTRY POSITIONING
==============================
The global nanoparticle analysis market remains moderately consolidated, with leading companies focusing heavily on AI integration, multi-modal analytical systems, nanoscale imaging technologies, and automated laboratory workflows.
Major companies operating in the market include:
• Malvern Panalytical
• Thermo Fisher Scientific
• Agilent Technologies
• HORIBA Scientific
• Bruker Corporation
• Anton Paar GmbH
• Beckman Coulter Life Sciences
• JEOL Ltd.
• Shimadzu Corporation
• Wyatt Technology (Waters Corporation)
• Oxford Instruments plc
• Particle Metrix GmbH
• Spectradyne LLC
• Postnova Analytics GmbH
• Biolin Scientific
• Izon Science Ltd.
• Other Key Players
Malvern Panalytical continues strengthening market positioning through advanced DLS and NTA characterization platforms supporting nanoparticle sizing, distribution analysis, and lipid nanoparticle validation across mRNA therapeutic development workflows.
HORIBA Scientific is expanding nanoscale spectroscopy innovation across pharmaceutical and cosmetic research ecosystems through advanced Raman-based molecular characterization technologies.
The competitive landscape is increasingly being shaped by:
AI-enabled analytical automation,
connected laboratory ecosystems,
cloud-based analytical platforms,
predictive nanoparticle modeling,
and integrated digital laboratory intelligence.
==============================
RECENT INDUSTRY DEVELOPMENTS & ANALYTICAL INNOVATION
==============================
In August 2025, HORIBA introduced the RZ-660 In Vivo Raman Analyzer, a non-invasive spectroscopy system designed for advanced skin and biological tissue analysis capable of micrometer-scale molecular characterization of lipids, hydration, and barrier function across pharmaceutical and cosmetic research applications.
In January 2025, Malvern Panalytical highlighted advances in lipid nanoparticle characterization using Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA) technologies to improve particle size measurement, stability analysis, and formulation reproducibility for mRNA drug delivery and nanomedicine applications.
A recent peer-reviewed publication in RSC Pharmaceutics by Agnieszka Siupa also highlighted the complementary use of NanoSight Pro and Zetasizer Advance Ultra technologies for comprehensive lipid nanoparticle characterization workflows supporting advanced pharmaceutical formulation analysis.
==============================
FUTURE OUTLOOK: AI LABORATORIES, EXOSOME THERAPEUTICS & DIGITAL BIOPHARMA ECOSYSTEMS
==============================
The future of the nanoparticle analysis market will increasingly be shaped by convergence between:
• AI-enabled laboratory ecosystems
• precision therapeutics
• exosome analytics
• digital biopharma workflows
• predictive pharmaceutical modeling
• nanoscale formulation science
• automated analytical platforms
• cloud-based characterization infrastructure
Growing demand for:
precision oncology,
personalized therapeutics,
exosome-based drug delivery,
biologics optimization,
and AI-driven pharmaceutical analytics
is expected to substantially increase the strategic importance of high-resolution nanoparticle characterization systems across global healthcare and biotechnology ecosystems.
As pharmaceutical R&D environments continue evolving toward intelligent laboratory automation and precision nanomedicine development, nanoparticle analysis platforms are expected to become one of the foundational analytical technologies supporting the next generation of biopharmaceutical innovation globally.
==============================
THE GLOBAL NANOPARTICLE ANALYSIS MARKET HAS BEEN SEGMENTED AS FOLLOWS:
==============================
By Technology
• Dynamic Light Scattering (DLS)
• Nanoparticle Tracking Analysis (NTA)
• Transmission Electron Microscopy (TEM)
• Scanning Electron Microscopy (SEM)
• Atomic Force Microscopy (AFM)
• X-Ray Diffraction (XRD)
• Small Angle X-Ray Scattering (SAXS)
• Others
By Product Type
• Instruments & Systems
• Standalone Analyzers
• Benchtop Systems
• Portable/Handheld Systems
• Hybrid/Multi-mode Systems
• Software & Data Analytics
• Integrated AI/ML-based Software
• Cloud-based Analytical Platforms
• Consumables & Accessories
By Particle Type Analyzed
• Metallic Nanoparticles
• Gold Nanoparticles
• Silver Nanoparticles
• Iron Oxide Nanoparticles
• Polymeric Nanoparticles
• Lipid-based Nanoparticles (LNPs)
• Liposomes
• Solid Lipid Nanoparticles
• Silica Nanoparticles
• Carbon-based Nanoparticles
• Quantum Dots
• Dendrimers
• Biological Nanoparticles
• Exosomes & Extracellular Vesicles
• Viruses & Viral Vectors
By Parameter Measured
• Particle Size & Size Distribution
• Zeta Potential (Surface Charge)
• Particle Concentration & Number Density
• Morphology & Shape Analysis
• Chemical Composition & Elemental Analysis
• Surface Area (BET Analysis)
• Molecular Weight
• Aggregation & Agglomeration Behavior
• Colloidal Stability
By End-use Industry
• Pharmaceutical & Biopharmaceutical
• Biotechnology & Life Sciences
• Healthcare & Clinical Diagnostics
• Chemicals & Specialty Chemicals
• Food & Beverage
• Cosmetics & Personal Care
• Environmental Monitoring & Testing
• Electronics & Semiconductors
• Energy & Battery Technology
• Defense & Aerospace
• Other Industries
==============================
KEY MARKET TRENDS
==============================
AI-enabled nanoparticle characterization platforms are accelerating deployment of automated analytical workflows and predictive pharmaceutical modeling systems.
Growing commercialization of lipid nanoparticle (LNP)-based therapeutics is significantly increasing demand for high-resolution nanoparticle sizing and stability analysis technologies.
Hybrid analytical workflows combining DLS, NTA, Cryo-TEM, spectroscopy, and AI-driven analytics are improving nanoscale characterization precision and operational efficiency.
Cloud-connected laboratory ecosystems are transforming nanoparticle analysis into intelligent, scalable, real-time analytical infrastructures across pharmaceutical and biotechnology environments.
Expansion of nanomedicine, exosome therapeutics, precision oncology, and gene therapy research is accelerating demand for advanced nanoscale analytical systems globally.
==============================
RESEARCH METHODOLOGY
==============================
The study integrates product-level benchmarking, pharmaceutical analytics intelligence, biotechnology ecosystem analysis, competitive positioning assessment, regional demand modeling, AI laboratory transformation analysis, and end-use industry evaluation across pharmaceutical, biotechnology, clinical diagnostics, semiconductor nanomaterials, and advanced research ecosystems.
Analytical frameworks include:
• market forecasting models
• competitive benchmarking
• pricing and cost structure analysis
• innovation intelligence
• laboratory workflow assessment
• ecosystem mapping
• pharmaceutical deployment analysis
• AI-driven analytical transformation analysis
• regional adoption modeling
The research further incorporates nanomedicine commercialization trends, mRNA therapeutic development, lipid nanoparticle formulation intelligence, biotechnology innovation analysis, precision medicine infrastructure assessment, and AI-enabled laboratory analytics trends to identify long-term strategic growth opportunities across the global nanoparticle analysis industry.
Access the Full Report & Strategic Insights: https://marketgenics.co/reports/nanoparticle-analysis-market-04132
==============================
RECOMMENDED REPORTS:
==============================
Medical Imaging AI Market: https://marketgenics.co/reports/medical-imaging-ai-market-37275
Smart Hospital Solutions Market: https://marketgenics.co/reports/smart-hospital-solutions-market-23854
Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
About MarketGenics
MarketGenics is a global market research and business advisory firm empowering decision-makers across startups, Fortune 500 companies, non-profit organizations, universities, and government institutions. The company delivers comprehensive market intelligence, industry analysis, and strategic insights across diverse sectors.
MarketGenics publishes detailed industry research reports combining granular quantitative analysis with expert insights on market trends, competitive landscapes, and emerging opportunities. These reports help organizations make informed strategic decisions, identify growth opportunities, and support sustainable business development.
In addition to research publications, MarketGenics supports organizations with strategic insights on product development, application modeling, market expansion strategies, and identifying niche growth opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nanoparticle Analysis Market to Reach USD 5.6 Billion by 2035 as AI-Based Drug Formulation, mRNA Delivery, and Multi-Modal Analytics Reshape Biopharma Research here
News-ID: 4503290 • Views: …
More Releases from MarketGenics Global Research
Infrared Detector Market to Surpass USD 0.9 Billion by 2035 as AI-Enabled Therma …
Wilmington, DE, USA, May 06, 2026 - According to MarketGenics Global Research, the global infrared detector market is valued at USD 0.5 billion in 2025 and is projected to reach USD 0.9 billion by 2035, expanding at a CAGR of 6.2% during the forecast period.
The market is entering a new phase of intelligent sensing transformation, where infrared detector technologies are rapidly evolving from specialized military imaging components into foundational sensing…
Laser Interferometer Market Size to Reach USD 0.7 Billion by 2035 as AI-Driven S …
Wilmington, DE, USA, May 06, 2026 - According to MarketGenics Global Research, the global laser interferometer market is valued at USD 0.4 billion in 2025 and is projected to reach USD 0.7 billion by 2035, expanding at a CAGR of 5.6% during the forecast period.
The market is entering a new phase of ultra-precision industrial transformation, where laser interferometers are evolving from specialized laboratory measurement instruments into foundational metrology systems supporting…
Microdisplay Market is Growing with a CAGR of 21.8% as AR Glasses, XR Computing, …
Wilmington, DE, USA, May 06, 2026 - According to MarketGenics Global Research, the global microdisplay market is valued at USD 2.8 billion in 2025 and is projected to reach USD 20.1 billion by 2035, expanding at a CAGR of 21.8% during the forecast period.
The industry is entering a high-growth commercialization phase as spatial computing ecosystems, AR/VR hardware platforms, defense modernization programs, and wearable computing architectures accelerate demand for ultra-compact, high-brightness,…
PTFE Tapes and Films Market Share, Growth & Forecast 2025-2035 | Asia Pacific Le …
Wilmington, DE, USA, 6th May 2026 - According to MarketGenics, the PTFE tapes and films market size is valued at USD 0.8 billion in 2025 and is projected to reach approximately USD 1.3 billion by 2035, expanding at a CAGR of 5.5% during the forecast period. The market growth is driven by increasing demand for high-performance PTFE materials across electronics, automotive, aerospace, and chemical processing industries, where thermal stability, chemical…
More Releases for Nanoparticle
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Nanoparticle Analysis Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Nanoparticle Analysis Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The nanoparticle analysis market encompasses a range of technologies and instruments used for the characterization and study of nanoparticles. With the increasing applications of nanoparticles…
Latest Trends In Global Nanoparticle Analyzer Market
A technique for observing and examining particles in liquids is called nanoparticle tracking analysis (NTA). Little particles (between 10 and 1000 nm) are suspended in a liquid using NTA, enabling the creation of a size distribution profile.
Nanotechnology is a vast area of study that focuses on materials and uses that take place at extremely small scales.To determine the size of individual particles and the size distribution range for a…
Cerium Oxide Nanoparticle Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Cerium Oxide Nanoparticle market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This report…
ORU Scientist Helps Develop Novel Nanoparticle Technology
Tulsa, OK – Oral Roberts University Scientist, Dr. Enrique Valderrama-Araya, who in collaboration with material scientists from Brazil, China, the UK, and the USA, has developed a novel hydrogen evolution reaction for exploring the extent of platinum nanoparticles dissolution upon the surface of carbon nanostructured electrodes.
The team’s research, recently published in Nanoscale, a high impact international journal, demonstrated how platinum nanoparticles can potentially be used to cheaply mass manufacture catalyst…
Titanium Dioxide Nanoparticle Market Research Report 2020
The research report published by Market desk.us based on the Global Titanium Dioxide Nanoparticle Market Report 2020 aims to deliver an explicit evaluation of the market. This report gives insights extracted by thoroughly analyzing past and current developments in the market. It also provides par excellence futuristic estimations for different vital factors including Titanium Dioxide Nanoparticle market size, share, net profit, sales, revenue, and growth rate.
Get Sample PDF of Titanium…
